IL6 and metabolic disease: Second, the retrospective nature of the study limited our ability to measure other measures of metabolic disease, including waist circumference, and visceral adipose tissue, and measures of inflammation, such as C-reactive protein, procalcitonin, and interleukin-6 levels.